X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88) 88
female (66) 66
male (63) 63
adult (58) 58
middle aged (54) 54
clinical neurology (53) 53
multiple sclerosis (48) 48
index medicus (47) 47
magnetic resonance imaging (30) 30
neurosciences (27) 27
optic neuritis (27) 27
mri (23) 23
adolescent (22) 22
aged (21) 21
brain (18) 18
risk (16) 16
multiple-sclerosis (15) 15
multiple sclerosis - pathology (14) 14
analysis (13) 13
brain - pathology (13) 13
follow-up studies (13) 13
acute disease (11) 11
animals (11) 11
cerebrospinal fluid (11) 11
cerebrospinal-fluid (11) 11
child (11) 11
treatment outcome (11) 11
young adult (11) 11
diagnosis (9) 9
follow-up (9) 9
lesions (9) 9
multiple sclerosis - cerebrospinal fluid (9) 9
multiple sclerosis - diagnosis (9) 9
multiple sclerosis - immunology (9) 9
optic neuritis - cerebrospinal fluid (9) 9
optic neuritis - immunology (9) 9
surgery (9) 9
biomarkers (8) 8
denmark (8) 8
disability (8) 8
further section (8) 8
obesity (8) 8
optic neuritis - diagnosis (8) 8
risk factors (8) 8
time factors (8) 8
astrophysics (7) 7
central-nervous-system (7) 7
csf (7) 7
magnetic fields (7) 7
magnetic resonance imaging - methods (7) 7
multiple sclerosis - complications (7) 7
optic neuritis - physiopathology (7) 7
physics - high energy astrophysical phenomena (7) 7
research (7) 7
studies (7) 7
abridged index medicus (6) 6
age (6) 6
article (6) 6
criteria (6) 6
disease (6) 6
double-blind method (6) 6
high energy astrophysical phenomena (6) 6
medicin och hälsovetenskap (6) 6
multiple sclerosis - drug therapy (6) 6
neurology (6) 6
oligoclonal bands (6) 6
prospective studies (6) 6
alzheimer's disease (5) 5
astrophysics - high energy astrophysical phenomena (5) 5
biomarkers - cerebrospinal fluid (5) 5
cardiovascular diseases (5) 5
care and treatment (5) 5
disease progression (5) 5
disease-activity (5) 5
hematology (5) 5
immunoglobulin g (5) 5
immunology (5) 5
lymphocytes (5) 5
medical and health sciences (5) 5
medical research (5) 5
medicine, general & internal (5) 5
multiple sclerosis - physiopathology (5) 5
multiple-sclerosis patients (5) 5
ophthalmology (5) 5
optic neuritis - etiology (5) 5
optic neuritis - pathology (5) 5
physics (5) 5
predictive value of tests (5) 5
prognosis (5) 5
proportional hazards models (5) 5
severity of illness index (5) 5
system (5) 5
vep (5) 5
acute optic neuritis (4) 4
aged, 80 and over (4) 4
atrophy (4) 4
biochemistry & molecular biology (4) 4
blood-brain barrier (4) 4
cardiovascular diseases - prevention & control (4) 4
clinical trials (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the Neurological Sciences, ISSN 0022-510X, 2009, Volume 285, pp. S201 - S201
Journal Article
Journal Article
by Jansen, W.J and Ossenkoppele, R and Knol, D.L and Tijms, B.M and Scheltens, P.J and Verhey, F.R.J and Visser, P.J and Aalten, P and Aarsland, D and Alcolea, D and Alexander, M and Almdahl, I.S and Arnold, S.E and Baldeiras, I and Barthel, H and Berckel, B.N. van and Bibeau, K and Blennow, K and Brooks, D.J and Buchem, M.A. van and Camus, V and Cavedo, E and Chen, K and Chetelat, G and Cohen, A.D and ezga, A and Engelborghs, S and Fagan, A.M and Fladby, T and Fleisher, A.S and Flier, W.M. van der and Ford, L and Forster, S and Fortea, J and Foskett, N and Frederiksen, K.S and Freund-Levi, Y and Frisoni, G.B and Froelich, L and Gabryelewicz, T and Gill, K.D and Gkatzima, O and Gomez-Tortosa, E and Gordon, M.F and Grimmer, T and Hampel, H and Hausner, L and Hellwig, S and Herukka, S.K and Hildebrandt, H and Ishihara, L and Ivanoiu, A and Jagust, W.J and Johannsen, P and Kandimalla, R and Kapaki, E and Klimkowicz-Mrowiec, A and Klunk, W.E and Kohler, S and Koglin, N and Kornhuber, J and Kramberger, M.G and Laere, K. Van and Landau, S.M and Lee, D.Y and Leon, M and Lisetti, V and Lleo, A and Madsen, K and Maier, W and Marcusson, J and Mattsson, N and Mendonca, A. de and Meulenbroek, O.V and Meyer, P.T and Mintun, M.A and Mok, V and Molinuevo, J.L and Mollergard, H.M and Morris, J.C and Mroczko, B and Mussele, S. Van der and Na, D.L and Newberg, A and Nordberg, A and Nordlund, A and Novak, G.P and Paraskevas, G.P and Parnetti, L and Perera, G and Peters, O and Popp, J and Prabhakar, S and Rabinovici, G.D and Ramakers, I.H and Rami, L and Oliveira, C.R and Rinne, J.O and Roigue, K.M and Roiguez-Roiguez, E and ... and Amyloid Biomarker Study Grp and Amyloid Biomarker Study Group and Sahlgrenska akademin and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy
Jama : Journal of the American Medical Association, ISSN 0098-7484, 2015, Volume 313, Issue 19, pp. 1924 - 1938
Journal Article
Journal Article
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article